Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

resebidrag France

Reference number
Coordinator DOUBLE BOND PHARMACEUTICALS AB - Double Bond Pharmaceutical AB
Funding from Vinnova SEK 10 000
Project duration November 2017 - January 2018
Status Completed
Venture Travel grant
Call Travel grant for building international consortia

Purpose and goal

Information about Double Bond Pharmaceutical and products Temodex SA033 was presented for potential partners (Ipsen and Servier) as well as VC companies (like for example Industriefonden)

Expected results and effects

The meetings were in accordance to the plan

Planned approach and implementation

The meetings were in accordance to the plan

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2017-04709

Page statistics